Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD

SHANGHAI, Feb. 24, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the company has entered into the strategic collaboration with Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK). Under the collaboration, the parties […]


2 w.
Science
ID: -3652710833786189419


Similar News expand_more


Science
Science
Technology
Technology
Science
Economics
Technology
Science
Science
Science
Science
Technology
Science
Technology
Economics
Science
Technology
Science
Technology
Science
Science
Technology
Technology
Science
Science
Science
Technology
Technology
Science
Technology
Science
Economics
Technology
Technology
Technology
Technology
Military
Science
Science
Technology
Education
Technology
Technology
Technology
Technology
Technology
Technology
Economics
Technology
Add Watch Country

arrow_drop_down